This trial is evaluating whether Adherence Promotion With Person-centered Technology (APPT) System will improve 3 primary outcomes, 8 secondary outcomes, and 1 other outcome in patients with Treatment Adherence. Measurement will happen over the course of Assessed at baseline, predicting adherence variables over 6 months.
This trial requires 190 total participants across 2 different treatment groups
This trial involves 2 different treatments. Adherence Promotion With Person-centered Technology (APPT) System is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"The findings from this initial single-center study do not provide evidence to support the belief that adherence is a disease-treatment variable that can be cured. However, studies utilizing multi-center and long-term follow-up studies can provide more evidence of a causal relationship between adherence to health care and adherence to disease-treatment goals in individuals with schizophrenia or bipolar disorder." - Anonymous Online Contributor
"Patients with no signs of nonadherence may be more likely to be from working-class families or racial groups that tend not to seek or adhere to conventional clinical treatment regimens." - Anonymous Online Contributor
"By 2011, almost half of patients treated for schizophrenia (46%) and over one third of those treated for bipolar disorder (31%) didn't receive adequate treatment. In a recent study, findings of this analysis illustrate the scope of the problem of inadequate treatment adherence: a public health priority that needs further in-depth examination. The findings also highlight the importance of monitoring treatment adherence, and improving both provider-to-patient communication and provider motivation to adhere to treatment guidelines." - Anonymous Online Contributor
"Patients should be actively involved in the treatment decision-making process. A greater understanding about treatment adherence and its components, and strategies to increase compliance, are important for improved treatment outcomes." - Anonymous Online Contributor
"While some studies have found low adherence rates with other chronic conditions, current evidence suggests that, overall, adherence to treatment is not extremely low in LN for any given medication. It appears that many people who acquire LN may begin therapy at some point and subsequently become adherent, however this may occur late in the disease. Efforts to improve adherence should be made as our chances of surviving and successfully treating LN increase as treatment options become more complicated and costly, with more side-effects." - Anonymous Online Contributor
"Most doctors consider adherence to treatment to be an important cause of good outcomes and help to keep patients with problems with chronic disease out of hospital. Doctors and patients need to communicate on the issues so that treatment can be tailored to each individual's needs." - Anonymous Online Contributor
"Lack of adherence to drug therapy is an important cause of therapeutic failure in patients with serious diseases. However, the primary cause of poor adherence to drugs was perceived as related to side effects (34.9%), rather than drug characteristics (27.2%). Further investigations are needed into the reasons for poor adherence, in order to develop strategies that will improve adherence to medication in patients with severe diseases." - Anonymous Online Contributor
"Appt was a reliable treatment delivery system to improve patient's life in routine work and promote the health of the population. The findings have significant policy implications for improving access to and quality of pharmaceutical adherence support services in China." - Anonymous Online Contributor
"Results from a recent clinical trial confirms the effectiveness of an appt communication technology system in improving medication adherence to antiretroviral prescription medications for HIV-infected adolescents. Future research should focus on the long-term potential impact of the intervention to assess adherence with or without use of other adjunctive interventions." - Anonymous Online Contributor
"There is much debate among researchers as to whether we should look at an individual's baseline (prior to the intervention) and how this will change over time. Furthermore, there is debate as to whether an individual's previous treatment history influences adherence, whether current treatment can be used to predict adherence, whether change in adherence over time is predictable and whether intervention strategies can be better tailored to the individual. While there are many barriers to patient adherence, there has yet to be a one-size-fits-all approach to achieving adherence. Instead, the tailored approach (i.e. which approach is best for this individual over time) may be more effective, both in the short and long term." - Anonymous Online Contributor
"A PCT system provided effective promotion of patient-centered technology use. Use of the tool significantly improved patient satisfaction, increased medication and product information, and promoted the use of patient-centered electronic medical records and personal health record(s)." - Anonymous Online Contributor
"The degree of adherence reported after starting IFNalpha therapy was moderate and negatively correlated with adverse events and virological viral rebound. Adverse events in our study were frequently mild, and the absence of symptoms did not preclude adherence. Adherence to IFNalpha therapy can be improved by the administration of a daily diary." - Anonymous Online Contributor